CCNE1 Is a Novel Synthetic Lethal Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma

被引：0
|
作者：
Kawahara, Naoki [1 ]
Yamada, Yuki [1 ]
Kawaguchi, Ryuji [1 ]
机构：
[1] Nara Med Univ, Dept Obstet & Gynecol, Nara, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3026
引用
收藏
页码：1845 / 1845
页数：1
相关论文
共 50 条
  • [41] Alanine metabolism is an ARID1A-dependent vulnerability in clear cell ovarian carcinoma
    Nie, Hao
    Zhou, Wei
    Wang, Chen
    Zhang, Nan
    Wu, Shuai
    Zhang, Rugang
    CANCER RESEARCH, 2024, 84 (05)
  • [42] Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, Daichi
    Mao, Tsui-Lien
    Fukayama, Masashi
    Nakagawa, Shunsuke
    Yano, Tetsu
    Taketani, Yuji
    Shih, Ie-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (12): : 5121 - 5129
  • [43] Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
    Choi, Jae Yoon
    Han, Hyun Ho
    Kim, Young Tae
    Lee, Joo Hyun
    Kim, Baek Gil
    Kang, Suki
    Cho, Nam Hoon
    YONSEI MEDICAL JOURNAL, 2017, 58 (01) : 59 - 66
  • [44] The role of chromatin remodeler protein ARID1a in ovarian clear cell carcinoma
    Lakshminarasimhan, Ranjani
    Andreu-Vieyra, Claudia
    Lawrenson, Kate
    Gayther, Simon A.
    Jones, Peter A.
    Liang, Gangning
    CANCER RESEARCH, 2016, 76
  • [45] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma.
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    LABORATORY INVESTIGATION, 2011, 91 : 259A - 259A
  • [46] Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
    Jones, Sian
    Wang, Tian-Li
    Shih, Ie-Ming
    Mao, Tsui-Lien
    Nakayama, Kentaro
    Roden, Richard
    Glas, Ruth
    Slamon, Dennis
    Diaz, Luis A., Jr.
    Vogelstein, Bert
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Papadopoulos, Nickolas
    SCIENCE, 2010, 330 (6001) : 228 - 231
  • [47] ARID1A gene silencing reduces the sensitivity of ovarian clear cell carcinoma to cisplatin
    Lyu, Changshuai
    Zhang, Yinglan
    Zhou, Xingnan
    Lang, Jinghe
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 4067 - 4071
  • [48] Ethnic variations in ARID1 a expression in clear cell and endometrioid ovarian carcinoma.
    Lai, Tiffany
    Vierkoetter, Koah
    Ayabe, Asia
    Ahn, Hyeong Jun
    Shimizu, David
    Terada, Keith Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] COMBINATIONAL TARGETING OF HDAC6 AND PD-1/PD-L1 IMMUNE CHECKPOINT IN ARID1A-MUTATED OVARIAN CANCERS
    Fatkhutdinov, Nail
    Fukumoto, Takeshi
    Zhang, Rugang
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 158 - 158
  • [50] Synthetic lethal approaches to target ARID1A deficient breast cancer
    Khalique, Saira
    Williamson, C. T.
    Pemberton, H.
    Wai, P. T.
    Menon, M.
    Brough, R.
    Leonidou, A.
    Peck, B.
    Natrajan, R. C.
    Lord, C. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 179 - 179
12345